Department of Pharmacology, School of Medicine, Showa University, Tokyo, Japan
Department of Chemistry, College of Arts and Sciences, Showa University, Yamanashi-ken, Japan
Department of Chemistry, College of Arts and Sciences, Showa University, Yamanashi-ken, Japan
Department of Healthcare and Regulatory Sciences, School of Pharmaceutics, Showa University, Tokyo, Japan
Saiyu Soka Hospital, Saitama-ken, Japan
Saiyu Soka Hospital, Saitama-ken, Japan
Saiyu Soka Hospital, Saitama-ken, Japan
Department of Pharmacology, School of Medicine, Showa University, Tokyo, Japan
Department of Pharmacology, School of Medicine, Showa University, Tokyo, Japan
Department of Pharmacology, School of Medicine, Showa University, Tokyo, Japan
Department of Pharmacology, School of Medicine, Showa University, Tokyo, Japan
Copyright © 2017 Yuya Nakamura, Masahiro Inagaki, Sachiyo Kenmotsu, Shiho Yamadera, Isao Ohsawa, Hiromichi Gotoh, Yoshikazu Goto, Naoki Sato, Tatsunori Oguchi, Mayumi Tsuji, Yuji Kiuchi et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
Nakamura, Y. , Inagaki, M. , Kenmotsu, S. , Yamadera, S. , Ohsawa, I. , Gotoh, H. , Goto, Y. , Sato, N. , Oguchi, T. , Tsuji, M. and Kiuchi, Y. (2017) Significance of Cu/Zn-Superoxide Dismutase Levels in Hemodialysis Patients: A Mini Review.
Modern Research in Inflammation,
6, 9-13. doi:
10.4236/mri.2017.62002.